Temple Lung Center: Advancing Research in ILD

Interstitial lung diseases (ILD) significantly impact patient morbidity and mortality. As an ILD Center of Excellence, the Temple Lung Center has established comprehensive programs for the evaluation and management of patients with a wide range of ILDs. This includes extensive clinical research and lung transplantation expertise.

By
April 28, 2025
2 min

Temple Health

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

#1

Temple Lung Center, Temple University

Philadelphia, PA
Key Differentiators
- Pulmonology
- Lung Transplantation
- Interstitial Lung Disease
#2

National Jewish Health

Denver, CO
Key Differentiators
- Pulmonology
- Interstitial Lung Disease
- Clinical Research
#3

University of California, San Francisco (UCSF) Medical Center

San Francisco, CA
Key Differentiators
- Pulmonology
- Interstitial Lung Disease
- Lung Transplantation
#4

Mayo Clinic

Rochester, MN
Key Differentiators
- Pulmonology
- Interstitial Lung Disease
- Lung Transplantation
#5

Johns Hopkins Medicine

Baltimore, MD
Key Differentiators
- Pulmonology
- Interstitial Lung Disease
- Clinical Research

Temple Lung Center: Advancing Research in ILD

Top Institutions in Pulmonary

Temple Lung Center, Temple University

National Jewish Health

University of California, San Francisco (UCSF) Medical Center

Mayo Clinic

Johns Hopkins Medicine

Original Source(s)

Temple Lung Center: Advancing Research in ILD

Related Content

Research advances in connective tissue disease-associated pulmonary arterial hypertension with an emphasis on the Chinese population

BMI Patterns in ILD Outcomes Examined

Evaluating Serum Surfactant Protein-D, KL-6, and Deep Learning Approaches on Chest X-rays for Lung Fibrosis Detection: A Prospective Observational Investigation